Skip to main content
. 2022 Apr 18;23(8):4441. doi: 10.3390/ijms23084441

Figure 5.

Figure 5

Kaplan–Meier estimates of recurrence-free interval according to ctDNA in colon cancer patients after adjuvant chemotherapy. ctDNA status after adjuvant chemotherapy in patients with colon cancer. (A) Stage II; ctDNA positivity immediately after completion of chemotherapy was associated with poorer RFS. From Tie et al., 2016 [21]. (B) In Stage III. From Tie et al. [123].